MedPath

Study on â??MADHUMEGAMâ?? (DIABETES MELLITUS) with the evaluation of trial drug â??GANDHAGA CHOORANAM.â??

Phase 2
Conditions
Health Condition 1: null- MALE AND FEMALE WITH DIABETES MELLITUS (TYPE II)
Registration Number
CTRI/2015/03/005618
Lead Sponsor
GOVERNMENT SIDDHA MEDICAL COLLEGE CHENNAI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Subjects within 3rd to 6th decade.

Blood glucose level(R) ranging from 170mg-300mg

Polyuria, polyphagia, polydipsia, nocturia

Noticeable weight loss

Fatigue, lethargy, tiredness

Peripheral neuritis,

Pruritis all over the body

Exclusion Criteria

Insulin dependent diabetes mellitus

Secondary diabetes.

Cardiovascular diseases

Diabetic nephropathy

Diabetic retinopathy

Vulnerable population such as Pregnant women, Lactating mothers,TB Affected individuals, HIV positive (Clinical History)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome is mainly assessed by reduction in clinical symptoms and reduction in HbA1C AND BLOOD GLUCOSE LEVELTimepoint: 48 DAYS
Secondary Outcome Measures
NameTimeMethod
Secondary outcome is assessed by comparing the safety parameters before and after treatment.Timepoint: 48 DAYS
© Copyright 2025. All Rights Reserved by MedPath